Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine

European Journal of Clinical Pharmacology

Volumn 50, Issue 3, 1996, Pages 195-201

  Bode, H ^a,b   Brendel, E ^b   Ahr, G ^b   Fuhr, U ^c   Harder, S ^c   Staib, A H ^c  

^a UNIVERSITY OF BONN   (Germany)

^b BAYER AG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

GI absorption; HF capsule; bioavailability; Intra individual variability; Nifedipine; Stable isotope labelled derivatives

Indexed keywords

CARBON; CARBON 13; NIFEDIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; GASTROINTESTINAL ABSORPTION; HUMAN; HUMAN EXPERIMENT; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CARBON ISOTOPES; COLON; CROSS-OVER STUDIES; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; NIFEDIPINE; STOMACH;

EID: 0029897299     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050092     Document Type: Article

References (32)

1. Abrahamsson B, Alpsten M, Hugosson M, Jonsson UE, Sundgren M, Sveheden A, Tölli J (1993) Absorption, gastrointestinal transit and tablet erosion of felodipine extended-release (ER) tablets. Pharm Res 10:709-714
2. Banditt P, Meyer FP (1990) Zur Pharmakokinetik von Nifedipin nach oraler und sublingualer Applikation. Z Klin Med 45:1243-1244
3. Bauer LA, Stenwall M, Horn JR, Davis R, Opheim K, Greene L (1986) Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil and diltiazem therapy. Clin Pharmacol Ther 40:239-242
4. de Boer A, Kluft C, Kasper FJ, Kroon JM, Schoemaker HC, Breimer DD, Soons PA, Cohen AF (1993) Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects. Br J Clin Pharmacol 35:99-104
5. Breimer DD, Schellens JHM, Soons PA (1989) Nifedipine: Variability in its kinetics and metabolism in man. Pharm Ther 44:445-454
6. Fuhr U, Hoyer J, Ritter W, Staib AH (1992) Differences in absorption of BAY u 3405 along the human gastrointestinal tract. Int J Clin Pharmacol Ther Toxicol 30:475-476
7. Fuhr U, Staib AH, Harder S, Becker K, Liermann D, Schöllnhammer G, Roed IS (1994) Absorption of Ipsapirone Along the Human Gastrointestinal Tract. Br J Clin Pharmacol 38:83-86
8. Gillespie WR, Veng-Peddersen P (1985) A Polyexponential Deconvolution. Method J Pharmacokinet Biopharm 13:289-307
9. Guengerich FP, Peterson LA, Böcker RH (1988) Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of Hantzsch pyridine esters. J Biol Chem 263:8176-8183
10. Harder S, Fuhr U, Beermann D, Staib AH (1990) Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the HF-capsule. Br J Clin Pharmacol 30:35-39
11. Horster FA, Duhm B, Maul W, Medenwald H, Patschke K, Wegner LA (1972) Klinische Untersuchungen zur Pharmakokinetik von radioaktiv markierten 4-(2-Nitrophenyl)-2,6-dimethyl-1,5-dihydropyridin-3,5-dicarbonsäure- dimethyl-ester. Arzneimittel Forsch 22:330-334
12. Hugemann B, Schuster O (1982) Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes. Ger Pat No DE 2928477 C3 (A 61 K 9/00)
13. van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD (1987) Negligible sublingual absorption of nifedipine. Lancet: 1363-1364
14. Lobo J, Jack DB, Kendall MJ (1986) The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers. Eur J Clin Pharmacol 30:57-60
15. Kleinbloesem CH, van Harten J, de Leede LGJ, van Brummelen P, Breimer DD (1984a) Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clin Pharmacol Ther 36:396-401
16. Kleinbloesem CH, van Brummelen P, van de Linde J, Voogd P, Breimer DD (1984b) Nifedipine: Kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 36:742-749
17. Kuhlmann J, Graefe KH, Rämsch KD, Ziegler R (1986) Clinical Pharmacology. In: Krebs R (ed) Treatment of cardiovascular diseases by Adalat (nifedipine). Schattauer, Stuttgart pp 93-144
18. Kurosawa N, Owada E, Ito K, Ueda K, Takahashi A, Kikuiri T (1985) Bioavailability of nifedipine suppository in healthy subjects. Int J Pharm 27:81-88
19. Murdoch D, Brogden RN (1991) Sustained release formulations: an appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart desease and peripheral vascular disorders. Drugs 41:737-779
20. Rämsch KD, Graefe KH, Scherling D, Sommer J, Ziegler R (1986a) Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine and nimodipine. Am J Nephrol 6 Suppl 1:73-80
21. Rämsch KD, Ziegler R (1986b) Plasma concentrations of various nifedipine formulations in healthy volunteers. In: Lichtlen PR (ed) New therapy of ischaemic heart disease and hypertension, 6th Int. Adalat Symp., Excerpta Medica. Amsterdam, pp 23-32
22. Renwick AG, Robertson DRC, Macklin B, Challenor VF, Waller DG, George CF (1988) The pharmacokinetics of oral nifedipine a population study. Br J Clin Pharmacol 25:701-708
23. Schellens JHM, Soons PA, Breimer DD (1988) Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem Pharmacol 37:2507-2510
24. Soons PA, de Boer AG, van Brummelen P, Breimer DD (1989) Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study. Br J Clin Pharmacol 27:179-189
25. Soons PA, Mulders TMT, Uchida E, Schoemaker HC, Cohen AF, Breimer DD (1993) Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics. Eur J Clin Pharmacol 44:163-169
26. Staib AH, Loew D, Harder S, Graul EH, Pfab R (1986) Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur J Clin Pharmacol 30:691-697
27. Staib AH, Rämsch KD, Ahr G, Liermann J, Spichalsky R, Albrecht W (1988) Absorption of nitrendipine and nisoldipine along the intestine of man (HF-capsule study). Naunyn Schmiedeberg's Arch Pharmacol 337 [Suppl]:R 125. Abstract 500
28. Staib AH, Beermann D, Harder S, Fuhr U, Liermann D (1989) Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am J Med 87:66-69
29. Terry RW (1982) Nifedipine therapy in angina pectoris: evaluation of safety and side-effects. Am Heart J 104:681-689
30. Watkins PB (1994) Intestinal Drug Metabolism, in: European Society for Biochemical Pharmacology, 14th European Workshop on Drug Metabolism, Université René Descartes. Faculté de Médicine, Paris, L36
31. Waller DG, Renwick AG, Gruchy BS, George CF (1984) The first pass metabolism of nifedipine in man. Br J Clin Pharmacol 18:951-954
32. Wingstrand K, Abrahamsson B, Edgar B (1990) Bioavailability from felodipine extended-release tablets with different dissolution properties. Int J Pharm 60:151-160